Chronic Bronchitis - Complete Notes With MCQs Practice

UNITY MEDICAL ACADEMY

ADULT HEALTH NURSING – I

CHRONIC BRONCHITIS

Complete Nursing Notes + NORCET MCQ Practice Test

1. Definition

Chronic bronchitis is a clinical condition characterized by a productive cough for at least 3 months in each of 2 consecutive years, after excluding other causes of chronic cough.

NORCET High-Yield:
Chronic bronchitis = productive cough + ≥3 months/year + for 2 consecutive years.

Chronic bronchitis is one of the major clinical phenotypes associated with Chronic Obstructive Pulmonary Disease (COPD), although not every person with chronic bronchitis necessarily has persistent airflow obstruction.

2. Types of Bronchitis

Type Characteristics
Acute Bronchitis Usually short-term inflammation of the bronchi, commonly associated with viral respiratory infections.
Chronic Bronchitis Long-standing productive cough meeting the clinical duration criterion. It may occur as part of the COPD spectrum.
Exam Tip: Do not confuse acute bronchitis with the clinical definition of chronic bronchitis.

3. Etiology and Risk Factors

Major Risk Factors

  • Cigarette smoking
  • Passive smoking
  • Long-term exposure to biomass smoke
  • Occupational dust exposure
  • Chemical fumes
  • Air pollution
  • Repeated airway irritation
  • Recurrent respiratory infections
  • Genetic susceptibility
Most important preventable risk factor: Tobacco smoking.

4. Pathophysiology

Chronic exposure to tobacco smoke / irritants
↓
Airway epithelial irritation
↓
Chronic airway inflammation
↓
Mucous gland enlargement + goblet cell hyperplasia
↓
Excess mucus production
↓
Impaired mucociliary clearance
↓
Airway narrowing
↓
Increased airway resistance
↓
Airflow limitation
↓
Ventilation-perfusion abnormality
↓
Hypoxemia ± Hypercapnia

5. Important Pathological Changes

A. Mucous Gland Enlargement

Chronic irritation can cause enlargement of mucus-producing glands, resulting in increased airway secretions.

B. Goblet Cell Hyperplasia

An increased number of goblet cells contributes to excessive mucus production.

C. Impaired Mucociliary Clearance

Smoking and chronic inflammation impair normal ciliary function. As a result, mucus and inhaled particles are cleared less effectively.

D. Airway Inflammation

Persistent inflammatory changes contribute to airway wall thickening, narrowing and airflow limitation.

E. Small Airway Obstruction

Mucus accumulation and inflammatory narrowing can obstruct smaller airways, especially during expiration.

6. Clinical Manifestations

Respiratory Symptoms

  • Chronic productive cough
  • Excess sputum production
  • Dyspnea
  • Wheezing
  • Chest discomfort or tightness
  • Reduced exercise tolerance
  • Difficulty clearing secretions

During Exacerbation

  • Increased cough
  • Increased sputum volume
  • Change in sputum character
  • Increased dyspnea
  • Worsening wheezing
  • Fatigue
  • Fever may occur when infection is present

7. Sputum Characteristics

Finding Possible Significance
Increased sputum Increased mucus production or exacerbation
Purulent sputum May occur during an infectious exacerbation
Blood-streaked sputum Requires assessment, especially if persistent or significant
Difficulty expectorating May indicate retained secretions
Nursing Alert: New hemoptysis should not automatically be attributed to chronic bronchitis; it requires appropriate clinical evaluation.

8. Assessment Findings

  • Chronic cough
  • Productive cough
  • Wheezing
  • Rhonchi or coarse breath sounds due to secretions
  • Prolonged expiration in associated airflow obstruction
  • Increased respiratory effort during exacerbation
  • Reduced oxygen saturation in advanced disease or acute deterioration
  • Possible cyanosis in significant hypoxemia

9. Diagnosis and Investigations

1. History and Physical Examination

The history should include smoking exposure, occupational exposure, duration and characteristics of cough, sputum production, dyspnea, exacerbations and functional limitation.

2. Spirometry

Spirometry is particularly important when COPD or persistent airflow obstruction is suspected.

Parameter Meaning
FEV₁ Forced expiratory volume in the first second
FVC Forced vital capacity
FEV₁/FVC Helps identify airflow obstruction
Important: The clinical definition of chronic bronchitis is based on the chronic productive cough criterion; spirometry is used to assess airflow obstruction and evaluate possible COPD.

3. Other Investigations When Indicated

  • Pulse oximetry
  • Arterial blood gas analysis
  • Chest X-ray
  • Sputum examination in selected cases
  • Complete blood count when clinically indicated
  • CT chest in selected patients

10. Medical Management

A. Smoking Cessation

  • Assess tobacco use.
  • Provide behavioral counseling.
  • Discuss evidence-based smoking cessation treatment.
  • Help the patient identify triggers.
  • Encourage avoidance of secondhand smoke.
Smoking cessation is a key intervention for patients who smoke.

B. Bronchodilators

Short-acting bronchodilators: May be prescribed for rapid relief of bronchospasm and symptoms.
LABA: Long-acting beta₂ agonists provide prolonged bronchodilation for maintenance treatment in appropriate COPD patients.
LAMA: Long-acting muscarinic antagonists provide prolonged bronchodilation and are commonly used as maintenance therapy in COPD.

C. Inhaled Corticosteroids

ICS may be prescribed for selected COPD patients according to clinical characteristics and exacerbation risk. They are not automatically indicated for every patient with chronic bronchitis.

D. Antibiotics

Antibiotics are not routinely required for every episode of increased cough or sputum. They may be considered when bacterial infection is clinically suspected and according to the treatment plan.

E. Oxygen Therapy

Oxygen may be prescribed for patients with significant hypoxemia according to clinical assessment and established indications.

In patients at risk of hypercapnic respiratory failure, oxygen should be carefully titrated according to the prescribed target and monitored appropriately.

11. Nursing Management

A. Respiratory Assessment

  • Monitor respiratory rate and pattern.
  • Assess depth and effort of breathing.
  • Monitor breath sounds.
  • Assess cough effectiveness.
  • Observe sputum amount, color and consistency.
  • Monitor SpO₂ as prescribed.
  • Assess for cyanosis.
  • Monitor mental status during deterioration.

B. Positioning

  • Place the patient in an upright position.
  • High-Fowler's position may improve lung expansion.
  • Allow a comfortable forward-leaning position if it helps relieve dyspnea.

C. Airway Clearance

  • Encourage effective coughing.
  • Teach controlled coughing techniques.
  • Encourage adequate hydration if not contraindicated.
  • Administer prescribed inhaled medications.
  • Monitor retained secretions.

D. Oxygen Administration

  • Administer oxygen as prescribed.
  • Monitor oxygen saturation.
  • Assess respiratory response.
  • Monitor ABG when clinically indicated.
  • Report deterioration promptly.

12. Controlled Coughing Technique

  1. Sit upright and relax the shoulders.
  2. Take a slow deep breath through the nose.
  3. Hold the breath briefly if comfortable.
  4. Open the mouth and cough effectively.
  5. Repeat as necessary without causing excessive fatigue.
The goal is to mobilize and remove secretions while minimizing unnecessary fatigue and airway irritation.

13. Pursed-Lip Breathing

  1. Relax the shoulders and neck.
  2. Inhale slowly through the nose.
  3. Purse the lips gently.
  4. Exhale slowly through the partially closed lips.
  5. Make expiration longer than inspiration.
Purpose: Helps slow expiration and may reduce dynamic airway collapse in patients with airflow obstruction.

14. Patient Education

  • Stop smoking.
  • Avoid secondhand smoke.
  • Avoid occupational and environmental respiratory irritants where possible.
  • Use inhalers correctly.
  • Follow the prescribed medication schedule.
  • Maintain recommended physical activity.
  • Practice breathing techniques.
  • Maintain adequate nutrition and hydration when appropriate.
  • Recognize worsening symptoms early.
  • Attend follow-up appointments.
  • Follow recommended vaccination advice.

15. Nutrition and Hydration

  • Provide small, frequent meals if large meals increase breathlessness.
  • Monitor body weight and nutritional status.
  • Encourage adequate protein and energy intake according to individual needs.
  • Maintain appropriate fluid intake unless contraindicated.
  • Allow adequate rest before meals.
Adequate hydration can help maintain less-viscous respiratory secretions in appropriate patients, making them easier to clear.

16. Complications

  • Recurrent respiratory infections
  • Acute exacerbations
  • Persistent airflow limitation when associated with COPD
  • Respiratory failure in advanced disease
  • Pulmonary hypertension
  • Cor pulmonale
  • Chronic hypoxemia
  • Secondary polycythemia associated with chronic hypoxemia
  • Reduced exercise tolerance
  • Weight loss and muscle wasting in advanced disease

17. Acute Exacerbation – Nursing Priorities

Assess Airway & Breathing
↓
Monitor Respiratory Rate + SpO₂
↓
Position Upright
↓
Administer Prescribed Bronchodilator / Oxygen
↓
Assess Response
↓
Evaluate for Infection / Respiratory Failure
↓
Escalate Care if Deteriorating
Emergency Warning Signs: Severe breathlessness, inability to speak comfortably, altered mental status, marked exhaustion, worsening hypoxemia or signs of respiratory failure require urgent assessment and escalation.

18. Chronic Bronchitis vs Emphysema

Feature Chronic Bronchitis Emphysema
Main pathology Airway inflammation and mucus hypersecretion Alveolar wall destruction and loss of elastic recoil
Typical symptom Productive cough Prominent dyspnea
Secretions Often increased Usually less prominent
Airway clearance Impaired by excess mucus Impaired airflow due to loss of elastic recoil and airway collapse
Hyperinflation May occur when airflow obstruction is present Common and prominent

19. Chronic Bronchitis vs Asthma

Feature Chronic Bronchitis/COPD Pattern Asthma
Course Usually chronic and progressive when associated with COPD Often variable
Airflow limitation Persistent when COPD is present Often variable/reversible
Smoking association Strong risk factor Not the defining cause
Cough Often chronic and productive May be dry or productive

20. NORCET High-Yield Points

  • Chronic bronchitis definition → productive cough for ≥3 months in each of 2 consecutive years.
  • Major preventable risk factor → cigarette smoking.
  • Major pathology → chronic airway inflammation + mucus hypersecretion.
  • Goblet cell hyperplasia → increased mucus production.
  • Smoking → impaired mucociliary clearance.
  • Classic symptom → chronic productive cough.
  • Spirometry → important when COPD/persistent airflow obstruction is suspected.
  • Pursed-lip breathing → prolonged expiration and reduced dynamic airway collapse.
  • Acute worsening → assess for COPD exacerbation/infection.
  • Severe dyspnea + confusion → possible respiratory failure.
  • Smoking cessation → key intervention.
  • LABA/LAMA → long-acting bronchodilation in appropriate COPD patients.
  • ICS → selected COPD patients, not automatically every patient.
  • Chronic hypoxemia → may cause secondary polycythemia.
  • Advanced pulmonary disease → may lead to pulmonary hypertension and cor pulmonale.

21. Quick Revision

Question Answer
Clinical definition of chronic bronchitis? Productive cough ≥3 months/year for 2 consecutive years
Major preventable risk factor? Tobacco smoking
Major pathological feature? Chronic airway inflammation and mucus hypersecretion
Important cellular change? Goblet cell hyperplasia
Important symptom? Chronic productive cough
Important test when COPD is suspected? Spirometry
Useful breathing technique? Pursed-lip breathing
Important lifestyle intervention? Smoking cessation
Possible advanced complication? Cor pulmonale

CHRONIC BRONCHITIS – NORCET MCQ TEST

25 Clinical & Concept-Based Questions

30:00

Time Limit: 30 Minutes

Question 1 of 25

Post a Comment

Welcome to UPNURSING NOTES

Previous Post Next Post